Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Safety and Tolerability Study of PP-001 Eye Drops in Healthy Adult Volunteers

NCT03769454 is registered in ClinicalTrials.gov with Panoptes Pharma GmbH as lead sponsor.

NCT NCT03769454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03769454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Safety and Tolerability Study of PP-001 Eye Drops in Healthy Adult Volunteers
Lead sponsor
Panoptes Pharma GmbH
Phase
Phase 1
Overall status
Completed
Start date
November 20, 2018
Completion date
March 15, 2022
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keratoconjunctivitis, ocular surface disease